General Electric Co’s healthcare unit the other day won U.S. Fda standards approval for the mammography device which causes three-dimensional images to detect cancer of the breast.

According on the company’s website, it, SenoClaire, uses imaging technology which combines low radiation-dosed X-rays from multiple angles to generate a superior mammogram.

The device is made of hardware and software upgrades into the company’s previously launched Senographe Essential 2D full-field digital mammography system.

The hardware upgrade produces multiple, low-dose x-ray projection images on the breast. It upgrade uses the low-dose X-ray images to produce cross-sectional views on the breast. (http://1.usa.gov/1uwffyf)

Hologic Inc developed the first 3-D breast imaging devices in 2001, which continuously dominate industry. Siemens AG submitted its application for the approval of the own 3-D breast imaging device in June.